Display options
Share it on

Facts Views Vis Obgyn. 2019 Sep;11(3):235-242.

Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or without Chemotherapy.

Facts, views & vision in ObGyn

L Turkgeldi, A Cutner, E Turkgeldi, A Al Chami, A Cassoni, N Macdonald, T Mould, A Nichol, A Olaitan, E Saridogan

Affiliations

  1. University College London Hospital, Women's Health Division, 250 Euston Road, London NW1 2PG, United Kingdom.
  2. Current address: 'Fulya Bahceci IVF Centre', Istanbul, Turkey.
  3. Current address: Koc University Hospital, Istanbul, Turkey.
  4. University College London Hospital, Cancer Division, 250 Euston Road, London NW1 2PG, United Kingdom.

PMID: 32082530 PMCID: PMC7020947

Abstract

BACKGROUND: Preservation of fertility in cancer patients of reproductive age is a concern for both the patient and the clinician. In this study, we aimed to study the effectiveness of laparoscopic ovarian transposition or ovariopexy in preserving ovarian function in women undergoing pelvic radiotherapy with or without chemotherapy for pelvic tumours.

METHODS: The records of patients who underwent laparoscopic ovarian transposition or ovariopexy prior to pelvic radiation therapy between 2002 and 2018 were reviewed retrospectively.

RESULTS: Thirty-nine women or adolescent girls with a diagnosis of cervical cancer (n=15), Hodgkin's lymphoma (n=6) or other types of pelvic tumours (n=18) were included in the study. The majority of patients had bilateral (n=25) or unilateral (n=8) ovarian transposition prior to radiotherapy. Nine out of 10 (90%) patients with soft tissue tumors, Ewing sarcoma or ependymoma, five out of seven (71.4%) patients with Hodgkin's lymphoma, two patients (100%) with rectal and anal cancer, and six out of 15 (40%) with cervical cancer retained ovarian function. Patients with cervical cancer, those who received concomitant chemotherapy and those older than 30 years were more likely to experience ovarian failure. Five patients conceived spontaneously and two women had four live births.

CONCLUSION: Laparoscopic repositioning of the ovaries out of the radiation field in order to protect ovarian function in patients receiving radiotherapy appears to be effective in the majority of patients. The procedure seems safe and should be considered either as a sole procedure or in association with other fertility preservation methods prior to pelvic radiotherapy.

Copyright © 2019 Facts, Views & Vision.

Keywords: Ovarian transposition; cancer; fertility preservation; ovariopexy; pelvic radiation

References

  1. J Hum Reprod Sci. 2015 Jan-Mar;8(1):3-13 - PubMed
  2. Gynecol Oncol. 1990 Nov;39(2):155-9 - PubMed
  3. Clin Med Insights Reprod Health. 2013 Mar 21;7:49-59 - PubMed
  4. Fertil Steril. 1998 Aug;70(2):381-3 - PubMed
  5. J Reprod Med. 2009 Apr;54(4):203-7 - PubMed
  6. J Reprod Med. 2004 Jul;49(7):573-4 - PubMed
  7. Expert Opin Pharmacother. 2015 May;16(7):1009-20 - PubMed
  8. J Ovarian Res. 2014 Jun 25;7:69 - PubMed
  9. Med Dosim. 2007 Fall;32(3):204-10 - PubMed
  10. Gynecol Oncol. 1995 Jan;56(1):3-7 - PubMed
  11. Am J Obstet Gynecol. 2003 Feb;188(2):367-70 - PubMed
  12. Cancer. 1996 Jun 15;77(12):2638-45 - PubMed
  13. Cancer. 1999 Nov 15;86(10):2138-42 - PubMed
  14. Fertil Steril. 2000 Oct;74(4):743-8 - PubMed
  15. Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):50-3 - PubMed
  16. Fertil Steril. 2013 Nov;100(5):1214-23 - PubMed
  17. Hum Reprod Update. 1998 May-Jun;4(3):248-59 - PubMed
  18. Lancet Oncol. 2013 Dec;14(13):e601-8 - PubMed
  19. J Obstet Gynaecol Res. 2011 Jul;37(7):825-9 - PubMed
  20. Hum Reprod. 1998 Mar;13(3):660-3 - PubMed
  21. Gynecol Oncol. 1993 May;49(2):206-14 - PubMed
  22. Fertil Steril. 2012 Jun;97(6):1387-93.e1-2 - PubMed
  23. Cancer. 1976 Feb;37(2 Suppl):1111-25 - PubMed
  24. J Minim Invasive Gynecol. 2017 Jan 1;24(1):28-35 - PubMed
  25. Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):445-450 - PubMed
  26. J Gastrointest Surg. 2009 Jun;13(6):1111-5 - PubMed
  27. Strahlenther Onkol. 1991 May;167(5):273-6 - PubMed
  28. Gynecol Oncol. 2007 Apr;105(1):234-7 - PubMed
  29. Curr Oncol. 2013 Dec;20(6):e602-7 - PubMed
  30. Fertil Steril. 2009 Mar;91(3):935.e15-6 - PubMed
  31. Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3418-25 - PubMed
  32. Curr Opin Obstet Gynecol. 2005 Feb;17(1):21-6 - PubMed
  33. Fertil Steril. 2003 May;79(5):1204-6 - PubMed
  34. J Reprod Med. 2015 Jul-Aug;60(7-8):354-8 - PubMed
  35. Nat Rev Endocrinol. 2013 Dec;9(12):735-49 - PubMed
  36. Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1304-12 - PubMed
  37. J Reprod Med. 2015 Jul-Aug;60(7-8):345-53 - PubMed
  38. Obstet Gynecol Surv. 2008 Nov;63(11):725-32 - PubMed
  39. Eur J Surg Oncol. 1990 Apr;16(2):141-6 - PubMed
  40. Reprod Biomed Online. 2009 Aug;19(2):250-1 - PubMed
  41. Curr Oncol. 2015 Aug;22(4):e294-304 - PubMed
  42. Acta Inform Med. 2013;21(2):135-7 - PubMed
  43. Hum Reprod Update. 2004 May-Jun;10(3):251-66 - PubMed
  44. Arch Gynecol Obstet. 2011 Aug;284(2):427-35 - PubMed
  45. Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):465-469 - PubMed
  46. Eur J Gynaecol Oncol. 2007;28(5):408-10 - PubMed
  47. Fertil Steril. 1998 Nov;70(5):956-60 - PubMed
  48. Fertil Steril. 2005 May;83(5):1547-9 - PubMed
  49. Int J Gynecol Cancer. 1994 Jan;4(1):61-65 - PubMed
  50. Int J Radiat Oncol Biol Phys. 1993 Feb 15;25(3):419-24 - PubMed
  51. Gynecol Oncol. 1987 Nov;28(3):255-61 - PubMed
  52. Am J Obstet Gynecol. 1958 Mar;75(3):590-600; discussion 600-5 - PubMed

Publication Types